Study Shows Gut Microbiota Diets Can Enhance the Effectiveness of Diabetes Medications

27th November, Hyderabad 2024: A first-of-its-kind clinical trial in India shows remarkable results for people with diabetes. The trial was conducted using BugSpeaks, a flagship technology of Leucine Rich Bio, India’s first microbiome-based company. BugSpeaks is a gut microbiome profiling test that provides nutritional recommendations based on the individual’s gut microbiota profile. With India being …

Genpact Shines in 2024 Avtar and Seramount Study, Securing ‘Hall of Fame’ for Women’s Empowerment

NEW DELHI, October 24, 2024—Genpact (NYSE: G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that it has been recognized as one of the 2024 Avtar and Seramount Best Companies for Women in India (BCWI) – and placed in the prestigious “Hall of Fame.” This marks Genpact’s fifth time being recognized in the study, highlighting its commitment to promoting gender diversity and building an inclusive workplace …